Clinical Trial Update: A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment [Phase 4]

View source ↗

Summary

This Phase 4 study of arzoxifene (LY353381) completed, evaluating continuation of treatment in patients who had previously benefited. The study encompassed brea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Endometrial Cancer
• Ovarian Cancer

Drugs mentioned

• Arzoxifene (arzoxifene)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Cancer, Endometrial Cancer | Phase 4 | Status: COMPLETED